A Clinical Trial of Mirror Treatment for Phantom Pain

Status Completed

Clinical Trial Summary

A randomized controlled clinical to examine the effect of mirror therapy on phantom pain and residual limb pain in patients with traumatic transtibial amputations in Cambodia. The study will be conducted with a semi-crossover design using self-rated pain and function as the main result variables.

Clinical Trial Description

The study will be conducted in two phases: Firstly, the effects of mirror treatment (M) versus tactile treatment (T) will be compared in an open, randomized, semi-cross-over case-control design study. The second phase includes the responders from the initial treatment (M or T), the duration of the initial treatment effect will be observed, and the effect of a second round of similar treatment will be registered.

Phase one: The study patients will be randomized for M or T treatment. The main outcome variables will be gathered before the initial randomization and after an initial treatment period of three weeks. Non-responders (NR) will be allocated for an immediate second three-weeks treatment period of combined treatment (M+T); the responders (R) of the M, T and M+T enter the second phase of the study. The M+T non-responders discontinue the study.

Phase two: The responders will be observed for a period of maximum three months. When symptoms of phantom limb pain and/or CRPS resume, the patients will undergo a second treatment period with the same treatment as during phase one. The duration of the second treatment period will be maximum three weeks, but each patient may decide to interrupt the treatment at an earlier stage if he finds the effect satisfactory. The main outcome indicators will be gathered at the start and the end of the second treatment period.

The study closes at the end of the second treatment period. For both study phases the treatment effects will be compared between the strata and also inside each stratum, using each patient as his own control. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02912975
Study type	Interventional
Source	Trauma Care Foundation, Norway
Contact
Status	Completed
Phase	N/A
Start date	March 2016
Completion date	July 15, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04060875` - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Active, not recruiting	`NCT02519907` - Surface Electrical Stimulation for Treatment of Phantom Limb Pain	N/A
Completed	`NCT02281539` - Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain	N/A
Completed	`NCT01608035` - Sciatic Perineural Versus Stump Catheter for Below Knee Amputation	Phase 0
Completed	`NCT03111277` - MR Guided Focused Ultrasound for Treatment of Neuropathic Pain	N/A
Recruiting	`NCT05188183` - Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response	N/A
Active, not recruiting	`NCT02221934` - Electrical Nerve Block for Amputation Pain	N/A
Active, not recruiting	`NCT03029884` - Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain	N/A
Completed	`NCT04538417` - C-RFA of Residual Limb Neuroma	N/A
Completed	`NCT03317600` - Postamputation Pain: Peripheral Mechanisms	N/A
Completed	`NCT01996254` - Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System	N/A
Terminated	`NCT00771862` - Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study	Phase 4
Completed	`NCT00462566` - The Efficacy of Motor Cortex Stimulation for Pain Control	N/A
Completed	`NCT05684445` - The Effect of Distant Reiki on Pain and Holistic Well-being	N/A
Completed	`NCT02784548` - Virtual Reality for Phantom Limb Pain	N/A
Active, not recruiting	`NCT05915065` - VR to Evaluate Phantom Limb Pain	N/A
Completed	`NCT00797849` - Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees	N/A
Enrolling by invitation	`NCT05807607` - Study of Lower-limb Phantom Pain Syndrome Using Peripheral Nerve and Spinal Cord Stimulation	N/A
Completed	`NCT03350061` - Prosthesis With Sensations	N/A
Active, not recruiting	`NCT06428123` - Comparison of Efficacy of Mirror Therapy vs Mental Imagery in Reduction of Phantom Limb Pain in AKAP	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.